DOD Biotech Public Co., Ltd.(TH:DOD)
฿0.71+0.03 (+4.41%)
TH:DOD
DOD Biotech Public Co., Ltd. financials statements
฿0.71
At close:+0.03 (+4.41%)
DOD Biotech Public Co., Ltd. (DOD) Income Statement
DOD Biotech Public Co., Ltd. Income Statement
Last quarter (Q2 2026), DOD Biotech Public Co., Ltd.'s total revenue was ฿122.18M, a decrease of 19.06% from the same quarter last year. In Q2, DOD Biotech Public Co., Ltd.'s net income was ฿930.00K. See DOD Biotech Public Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ฿ 608.98M | ฿ 645.38M | ฿ 678.15M | ฿ 537.16M | ฿ 1.02B | |
| ฿ 210.07M | ฿ 206.81M | ฿ 271.80M | ฿ 140.50M | ฿ 434.62M | |
| ฿ 182.98M | ฿ 163.31M | ฿ 206.05M | ฿ 163.05M | ฿ 126.84M | |
| Depreciation and Amortization | ฿ 42.99M | ฿ 60.67M | ฿ 73.47M | ฿ 64.50M | ฿ 67.04M |
| ฿ 70.08M | ฿ 104.89M | ฿ 130.61M | ฿ -352.63M | ฿ 338.82M | |
| ฿ 27.09M | ฿ 43.49M | ฿ 56.89M | ฿ -11.27M | ฿ 271.52M | |
| ฿ 16.36M | ฿ -3.00M | ฿ -8.01M | ฿ -6.99M | ฿ -6.46M | |
| ฿ 43.45M | ฿ 40.49M | ฿ 48.88M | ฿ -424.23M | ฿ 265.06M | |
| ฿ 59.59M | ฿ -159.33M | ฿ 7.19M | ฿ -345.12M | ฿ 233.10M | |
| Per Share Metrics | |||||
| Basic EPS | ฿ 0.13 | ฿ -0.35 | ฿ 0.02 | ฿ -0.84 | ฿ 0.57 |
| Diluted EPS | ฿ 0.13 | ฿ -0.35 | ฿ 0.02 | ฿ -0.84 | ฿ 0.57 |
| Weighted Average Shares Outstanding | 450.41M | 450.41M | 410.00M | 410.98M | 410.98M |
| Weighted Average Shares Outstanding (Diluted) | 450.41M | 450.41M | 435.31M | 410.98M | 410.98M |
Currency in THB
